Patient | Gender | Age (year) | Disease status | FAB subtype | WBC (×103/μL) | Blast purity (%) | Cytogenetics | MK-1775 IC50(nM) |
---|---|---|---|---|---|---|---|---|
AML#0 | Female | 13 | At diagnosis | M2 | 39.9 | 79 | 46, XX, t(8;21)(q22;q22) | 5996.5 |
AML#1 | Female | 50 | At diagnosis | M4 | 22.66 | 52 | 46, XX, del(5q), add(12p) | 2448.5 |
AML#2 | Male | 20 | At diagnosis | M2 | 23.55 | 42 | 45, X, -Y, t(8;21)(q22;q22) | 3204.0 |
AML#3 | Male | 4 | At diagnosis | M3 | 4.71 | 75 | 46, XY, t(15;17)(q22;q21) | 461.0 |
AML#4 | Male | 55 | At relapse | M2 | 5.64 | 14 | 46, XY, t(8;21)(q22;q22) | 844.0 |
AML#5 | Female | 57 | At relapse | M2 | 22.16 | 70 | 46, XX | 948.3 |
AML#6 | Male | 60 | At diagnosis | M3 | 1.83 | 86 | 46, XY, t(15;17)(q22;q21) | 233.7 |
AML#7 | Female | 53 | At relapse | M4 | 3.87 | 36 | 46, XX | 325.0 |
AML#8 | Male | 55 | At diagnosis | M2 | 3.87 | 32 | 46, XY | 887.9 |
AML#9 | Female | 35 | At relapse | M5 | 17.71 | 87 | 47, XX, +10, t(16;21)(p11;q22), add(11p) | 744.4 |
AML#10 | Male | 23 | At diagnosis | M2 | 25.89 | 53 | 46, XY, del(9q) | 439.7 |
AML#11 | Female | 43 | At diagnosis | M2 | 25.12 | 91 | 46, XX | 411.3 |
AML#12 | Male | 6 | At diagnosis | M3 | 93.99 | 85 | 46, XY, t(15;17)(q22;q21) | 277.5 |
AML#13 | Male | 52 | At diagnosis | M2 | 1.65 | 27 | 46, XY, t(11;15;17)(q25;q15;q21) | 3579.5 |
AML#14 | Female | 18 | At diagnosis | M3 | 1.62 | 64 | 46, XX | 9113 |
AML#15 | Female | 63 | At diagnosis | M2 | 0.6 | 23 | 46, XX | 344.1 |
AML#16 | Male | 38 | At diagnosis | M3 | 2.27 | 90 | 46, XY, t(15;17)(q22;q21) | 216.9 |
AML#17 | Female | 45 | At diagnosis | M4 | 1.52 | 36 | 46, XX | 3473.0 |
AML#18 | Female | 19 | At relapse | M2 | 21.55 | 52 | 46, XX, t(8;21)(q22;q22) | 1187.0 |
AML#19 | Male | 4 | At diagnosis | M4 | 77.32 | 41 | 46, XY | 5587.0 |
AML#21 | Male | 42 | At diagnosis | M4 | 10.60 | 51 | 46, XY/44, XY, -17, -19, (11q-?) | 1176.0 |
AML#22 | Female | 47 | At diagnosis | M5 | 244.53 | 80 | 46, XX | 1255.0 |
AML#23 | Male | 60 | At diagnosis | M5 | 2.10 | 81 | 46, XY, +2, +8, I(12)(q10) | 1480.0 |
AML#25 | Female | 12 | At diagnosis | M3 | 5.11 | 88 | 46, XX, t(15;17)(q22;q21) | 615.1 |
AML#26 | Male | 59 | At diagnosis | M2 | 129.98 | 81 | 46, XY | 5868.0 |
AML#27 | Female | 41 | At relapse | M4 | 40.20 | 24 | 47, XX,del(5q),+8,t(15;18)(q12,q23) | 6384.0 |
AML#29 | Male | 9 | At diagnosis | M4 | 68.14 | 31 | 46, XY, t(6;9)(p22;q34) | 880.4 |
AML#31 | Male | 17 | At diagnosis | M2 | 12.94 | 69 | 46, XY | 453.7 |
AML#32 | Female | 76 | At diagnosis | M5 | 13.93 | 85 | 46, XX | 2888.0 |